NYSE ARCA | ETF
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index.
The index is comprised of global companies expected to economically benefit from weight loss drug development.
The index includes pharmaceutical manufacturers, manufacturers of combination therapies and telehealth providers who provide access to Amylin agonists and analogs or GLP-1 agonists and analogs, including dual GLP-1 agonists and analogs.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| NVO | Novo Nordisk A/S | Healthcare | Drug Manufacturers - General | 18.99% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 17.82% |
| NOVO-B | Novo Nordisk A/S | Healthcare | Biotechnology | 14.90% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 9.41% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 9.39% |
| 4519 | Chugai Pharmaceutical Co. Ltd. | Healthcare | Drug Manufacturers - General | 8.90% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 7.46% |
| AZN | AstraZeneca PLC ADR | Healthcare | Drug Manufacturers - General | 7.13% |
| 4507 | Shionogi & Co. Ltd. | Healthcare | Drug Manufacturers - Specialty & Generic | 7.10% |
| ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 7.02% |
| 1801 | Innovent Biologics Inc | Healthcare | Biotechnology | 6.83% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 6.77% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 6.69% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 5.90% |
| ARWR | Arrowhead Pharmaceuticals Inc | Healthcare | Biotechnology | 5.84% |
| 1093 | CSPC Pharmaceutical Group Ltd | Healthcare | Drug Manufacturers - General | 5.73% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 5.26% |
| TEVA | Teva Pharma Industries Ltd ADR | Healthcare | Drug Manufacturers - Specialty & Generic | 4.96% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.79% |
| HIMS | Hims Hers Health Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.75% |